“In my opinion We can now say that there is a link between vaccination and blood clotting cases. We do not yet know what caused this reaction. In short, we will say that there is a relationship in the next few hours, but we still need to understand how these develop. [az agyi vénás trombózisok] – Said Marco Gavaleri, senior official of the European Pharmaceuticals Association (EMA) Ambassador Page.
All of this was frightening at first when someone was vaccinated with the British-Swedish astrogenic in recent days, but Cavalieri, who works on the EMA’s safety ethics committee, did not recommend that the authority say the drug should be suspended. As he put it: “Our assessment process is far from over. We will start making some preliminary recommendations this week, but we will not mention the age limits as various countries have already done. For the simple reason that we are a regulatory authority, we need more accurate risk / benefit data.”
According to the expert, when cerebral thrombosis diseases are low, hundreds of young people around the world die every day should be placed in another role of scales. In the interview, he says that this is considered possible because there is a link between the vaccine and different events, because this problem has become more common in vaccines than is common in the community in general. This phenomenon is mainly seen in women under 50 years of age, but also affects men aged 45-47 on average, who account for 20 percent of cases.
The most important symptom in Cavalier’s interview is that there is no treatment solution for this condition yet, he said. This is important because compatible use with the aspirin vaccine has begun in Hungary. “We are facing a situation where there are no platelets and thrombosis, so the use of some drugs will not help. We still do not know what this mechanism is. For example, we do not know if it is related to virus vectors. If this is true, it will also affect the evaluation of the use of vaccines,” said one EMA expert.
Regarding the use of AstraZeneca, he said he would look in more detail at how it works between different ages. Young women, who are often prone to thrombotic events, are at lower risk with covit than those of other ages. Cavalieri, on the other hand, believes that “studies should not forget that young women can also receive intensive treatment for the corona virus. Therefore, very careful work is needed to understand whether the risk-benefit balance is favorable for all ages. Vaccination.”
It’s too soon to panic
The E.M.A. Compared to its previous resolution Cavalieri really said nothing new. National Institute of Pharmacology and Food Health (OGYÉI) Symptom It has already been reported that a combination of hemorrhagic thrombosis and thrombocytopenia is sometimes very rare, sometimes following the administration of astrogen. This includes severe cases of venous thrombosis, sometimes with abnormal localized thrombosis such as cerebral sinus thrombosis or mesenteric vein and arterial thrombosis thrombocytopenia. “
For this reason, from the outset, “health professionals should monitor for signs and symptoms of thromboembolism and / or thrombocytopenia. People who experience neurological symptoms, including spotting (petechiae) a few days after being vaccinated, or if they do not develop at the injection site, should seek medical advice immediately. “
Therefore, for those who have been called for the vaccine, the most important thing is to consult their specialist or GP if they are trying to inject Astrogenogen.
Accident at the wrong time
Time is an unfortunate coincidence, it was Tuesday Telex was the first to write Vaccines are sent from the Well Valley, where the AstraZeneca vaccine is given. At least fifty people went there in the morning and no one received SMS or other notifications. According to the portal, the vaccine was discontinued due to an EMA expert report.
We know the reason is simple: a month ago, The March 6-7 weekend There was a vaccine mess in Hungary, many people were called via SMS to a remote vaccination site or were soon hospitalized without receiving the vaccine, perhaps not even AstraZeneca. The nationwide campaign then erupted, but they were vaccinated whether anyone stood in line or received an SMS.
But in the midst of administrative confusion, the organizers forgot another thing: instead of the first 4 weeks, the interval between the first and booster vaccines was increased to 12, meaning that the second dose of AstraZeneca would be given 84 days later instead of 28 days. But during the vaccine turmoil four weeks ago, reminder circles were written on callsheets at the original interval, which our paper learned from a vaccination center staffer.
In the case, we sent a question to the operational staff, from which the harassment charge was not confirmed on March 6, but the use of the British-Swedish product was not suspended.
“Vaccination with Astrogeneka has not been discontinued. A month ago some of the participants in the Astrogeneca vaccine appeared by mistake at the Kotwalki Clinic today. The second vaccination with Astrogeneka is no longer 4 weeks, but 12 weeks.
Some are already careful
In recent times, in many European countries, In Germany And in the Netherlands, vaccination of people under the age of 60 with the AstraZeneca vaccine was discontinued because there were people with brain thrombosis. There are currently no suspensions or restrictions in Hungary.
The international warning is that there are cases of cerebral thrombosis in geographically remote locations after vaccination. For example, “Germany reported 31 cases of cerebral thrombosis (1/90 thousand vaccines) while IMA analyzed 62 CVSTs (i.e. cerebral sinus thrombosis) collected worldwide (1/210 thousand vaccines) . Most cases 4– 16 days after vaccination. “EMA maintains that there is no proven cause between vaccination and freezing disorders, and that the health benefits of the vaccine far outweigh the risks,” Dobson wrote. Sopolks is a pharmaceutical licensee, pharmacologist In your Facebook post Even earlier this month. In the EU alone, 24 million doses of AstraZeneca were given by Sunday.